Search Within

Martin Stuart Tallman

  1. "Dermatology Service"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (6)
  2. Center for Hematologic Malignancies (6)
  3. Department of Medicine (6)
  4. Dermatology (6)
  5. Dermatology Service (6)
  6. Division of Subspecialty Medicine (6)

More Groups

People
  1. Jae Park (6)
  2. Mario Lacouture (5)
  3. Omar Abdel-Wahab (4)
  4. Michael Berger (3)
  5. Ross Levine (3)
  6. Sean Devlin (3)

More People

Years
  1. 2022 (1)
  2. 2015 (2)
  3. 2014 (1)
  4. 2013 (2)
Publications
  1. Blood (3)
  2. British Journal of Haematology (1)
  3. Journal of the American Academy of Dermatology (1)
  4. New England Journal of Medicine (1)
Publishers
  1. American Society of Hematology (3)
  2. John Wiley & Sons (1)
  3. Massachusetts Medical Society (1)
  4. Mosby Elsevier (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos) – Associated distinct purpuric subtype of toxic erythema of chemotherapy: A retrospective review of 54 patients
    Research Letter

    Stoll, J. R.; Battle, L.; Moy, A.; Dusza, S. W.; Park, J. H.; Tallman, M. S.; Taylor, J.; Markova, A.
    Journal of the American Academy of Dermatology (2022)

    Fulltext@MSK | Save
  • Targeting mutant BRAF in relapsed or refractory hairy-cell leukemia
    Journal Article

    Tiacci, E.; Park, J. H.; De Carolis, L.; Chung, S. S.; Broccoli, A.; Scott, S.; Zaja, F.; Devlin, S.; Pulsoni, A.; Chung, Y. R.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Melanoma and non-melanoma skin cancers in hairy cell leukaemia: A Surveillance, Epidemiology and End Results population analysis and the 30-year experience at Memorial Sloan Kettering Cancer Center
    Journal Article

    Watts, J. M.; Kishtagari, A.; Hsu, M.; Lacouture, M. E.; Postow, M. A.; Park, J. H.; Stein, E. M.; Teruya-Feldstein, J.; Abdel-Wahab, O.; Devlin, S. M.; more...
    British Journal of Haematology (2015)

    Fulltext@MSK | Save
  • Vemurafenib has potent antitumor activity in patients with relapsed/refractory BRAF mutant hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Kim, E.; Saven, A.; Wadleigh, M.; Stone, R. M.; Barrientos, J. C.; Rai, K. R.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Increased incidence of melanoma and non-melanoma skin cancers in patients with hairy cell leukemia: A single institution experience with 267 patients from Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Watts, J. M.; Kishtagari, A.; Devlin, S.; Stein, E. M.; Park, J. H.; Lacouture, M. E.; Tallman, M.
    Blood (2013)

    Fulltext@MSK | Save
  • Phase II trial of the BRAF inhibitor, vemurafenib, in patients with BRAF mutant relapsed or refractory hairy cell leukemia
    Meeting Abstract

    Park, J. H.; Chung, S. S.; Chung, Y. R.; Won, H.; Teruya-Feldstein, J.; Berger, M.; Khawaja, T. T.; Lacouture, M. E.; Levine, R. L.; Abdel-Wahab, O.; more...
    Blood (2013)

    Fulltext@MSK | Save